The FDA is working to address the coronavirus disease 2019 (COVID-19) outbreak and keep you and your family informed on the latest developments. Here are answers to some frequently asked questions from consumers about vaccines, treatments, and ivermectin.
Q: Should I get a booster shot or an additional shot of a COVID-19 vaccine?
A: On Aug. 12, the FDA updated the emergency use authorizations (EUA) for the Pfizer-BioNTech and Moderna COVID-19 vaccines to allow for the use of an additional dose in certain immunocompromised people.
On Sept. 22, the FDA amended the EUA for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series in:
- People 65 and older.
- People ages 18 to 64 at high risk of severe COVID-19.
- People ages 18 to 64 whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19, including severe COVID-19.
Q: Should I take ivermectin to prevent or treat COVID-19?
A: No. Although there are approved uses for ivermectin in people and animals, it is not approved for the prevention or treatment of COVID-19. Read more about why you should not use ivermectin to treat or prevent COVID-19.
Read this Consumer Update to learn more about some of the available COVID-19 treatments and how to get more information about them.
Q: Who should I contact with drug-related questions?
A: If you have additional questions, call the FDA’s Division of Drug Information at 855-543-3784 or email us at druginfo@fda.hhs.gov.
For the latest information about COVID-19, visit:
|